EUROPEAN JOURNAL OF HEART FAILURE

Scope & Guideline

Empowering clinicians with cutting-edge heart failure knowledge.

Introduction

Immerse yourself in the scholarly insights of EUROPEAN JOURNAL OF HEART FAILURE with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN1388-9842
PublisherWILEY
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 1999 to 2024
AbbreviationEUR J HEART FAIL / Eur. J. Heart Fail.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address111 RIVER ST, HOBOKEN 07030-5774, NJ

Aims and Scopes

The European Journal of Heart Failure focuses on the latest advances in heart failure research, treatment, and management. It serves as a crucial platform for disseminating innovative findings and clinical practices that contribute to improving patient outcomes in heart failure management.
  1. Heart Failure Mechanisms and Pathophysiology:
    Research exploring the biological mechanisms underlying heart failure, including genetic, molecular, and cellular factors that contribute to disease progression.
  2. Clinical Management and Treatment Strategies:
    Studies evaluating the efficacy and safety of various treatment modalities, including pharmacological therapies, device interventions, and lifestyle changes for heart failure patients.
  3. Epidemiology and Risk Factors:
    Investigations into the prevalence, incidence, and risk factors associated with heart failure across different populations, with an emphasis on comorbidities and demographic influences.
  4. Diagnostic Approaches:
    Research focused on the development and validation of diagnostic tools and biomarkers for the early detection and accurate classification of heart failure.
  5. Health Economics and Patient Outcomes:
    Analysis of healthcare resource utilization, cost-effectiveness of treatments, and the impact of heart failure on quality of life and long-term outcomes.
  6. Innovative Technologies:
    Studies on the application of new technologies, such as telemedicine, remote monitoring, and machine learning, to enhance heart failure management and patient care.
The journal has identified several trending themes that reflect the evolving landscape of heart failure research and clinical practice. These emerging topics may offer new insights and directions for future studies.
  1. Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors:
    A notable increase in research surrounding SGLT2 inhibitors as a treatment option for heart failure, highlighting their multifaceted benefits beyond glycemic control.
  2. Heart Failure with Preserved Ejection Fraction (HFpEF):
    Growing attention on HFpEF, with an emphasis on understanding its unique pathophysiology, diagnostic criteria, and treatment challenges.
  3. Telemedicine and Remote Monitoring:
    Emerging themes in the utilization of telemedicine and remote monitoring technologies for managing heart failure, particularly in light of the COVID-19 pandemic.
  4. Machine Learning and Artificial Intelligence:
    Increasing integration of machine learning and AI in predicting heart failure outcomes, enhancing diagnostics, and personalizing treatment strategies.
  5. Comorbidities and Multimorbidity:
    A trend towards understanding the interplay between heart failure and other chronic conditions, focusing on comprehensive care approaches that address multiple comorbidities.
  6. Patient-Centered Care and Quality of Life:
    A shift towards research that emphasizes patient-reported outcomes, quality of life assessments, and the psychosocial aspects of living with heart failure.

Declining or Waning

While the journal has seen a surge in certain themes, some areas of focus appear to be declining. This shift may reflect changes in clinical priorities or emerging research interests.
  1. Traditional Pharmacotherapy Alone:
    There seems to be a diminishing focus on studies solely centered around traditional pharmacological treatments for heart failure, with increasing interest in combination therapies and innovative approaches.
  2. Generalized Heart Failure Definitions:
    The use of broad, non-specific definitions of heart failure is becoming less prominent, as more precise phenotyping and tailored approaches are being favored in recent research.
  3. Single-Center Studies:
    The prevalence of single-center studies is declining in favor of multi-center and large cohort studies, which provide more generalizable findings and insights into heart failure management.
  4. Basic Science without Clinical Relevance:
    Research that lacks direct clinical applicability or insights into patient care is receiving less attention, as the journal increasingly prioritizes studies that bridge laboratory findings with clinical implications.

Similar Journals

Anatolian Journal of Cardiology

Exploring Innovative Pathways in Cardiovascular Medicine.
Publisher: KARE PUBLISSN: 2149-2263Frequency: 12 issues/year

The Anatolian Journal of Cardiology, published by KARE PUBL, stands as a vital resource in the field of Cardiology and Cardiovascular Medicine. With an ISSN of 2149-2263 and E-ISSN 2149-2271, this Open Access journal has been fostering the dissemination of critical research since 2001, ensuring that high-quality content is freely available to a global audience. Based in Turkey, the journal aims to bridge gaps in cardiological knowledge through rigorous peer-reviewed articles that span a wide range of topics, from innovative clinical practices to groundbreaking research findings. While its current ranking places it in the Q3 category of cardiology journals, the Anatolian Journal of Cardiology continues to strive towards enhancing its impact, currently holding a Scopus rank of 236 out of 387. Researchers, practitioners, and students alike will find this journal an essential platform for keeping abreast of the latest developments in cardiovascular health.

Kardiologia Polska

Bridging Knowledge and Practice in Cardiology
Publisher: POLISH CARDIAC SOCISSN: 0022-9032Frequency: 12 issues/year

Kardiologia Polska, the esteemed journal of the Polish Cardiac Society, has established itself as a vital resource in the field of cardiology and cardiovascular medicine since its inception in 1954. With an ISSN of 0022-9032 and an E-ISSN of 1897-4279, this journal serves as a platform for groundbreaking research and scholarly articles that contribute to the advancement of heart health. Although currently not an open access journal, it remains an essential reference for practitioners and researchers seeking to stay abreast of the latest developments in cardiovascular science. The journal reflects its scholarly depth through a Category Quartile of Q3 and a commendable Scopus ranking at the 48th percentile in its field. Published primarily in Poland, it caters to a global audience eager to explore comprehensive studies spanning clinical cardiology, innovative therapeutic approaches, and emerging cardiovascular trends. Join a thriving academic community by engaging with the invaluable insights and research contributions found within the pages of Kardiologia Polska.

CARDIOVASCULAR RESEARCH

Connecting research to real-world cardiovascular solutions.
Publisher: OXFORD UNIV PRESSISSN: 0008-6363Frequency: 18 issues/year

CARDIOVASCULAR RESEARCH, published by Oxford University Press, is a premier academic journal dedicated to the evolving field of cardiology and cardiovascular medicine. With a remarkable impact factor reflecting its significant contribution to the scientific community, this journal maintains a Q1 ranking in both Cardiology and Physiology categories, demonstrating its commitment to publishing high-quality research that influences clinical practices and healthcare outcomes. Established in 1967, the journal has consistently provided a platform for innovative studies and reviews, aiming to advance our understanding of cardiovascular physiology and pathology. Researchers, professionals, and students will find published articles crucial for their work, as the journal covers a broad spectrum of topics including molecular biology, genetics, and clinical studies. While currently not offering open access options, CARDIOVASCULAR RESEARCH remains accessible through institutional and individual subscriptions, ensuring that the latest findings are available to those in the cardiovascular science community.

REVISTA ESPANOLA DE CARDIOLOGIA

Advancing Cardiovascular Knowledge with Every Issue
Publisher: EDICIONES DOYMA S AISSN: Frequency: 12 issues/year

REVISTA ESPANOLA DE CARDIOLOGIA is a premier journal dedicated to the dynamic field of cardiology, published by EDICIONES DOYMA S A in Barcelona, Spain. With an impressive Q1 status in the Medicine (miscellaneous) category for 2023, this journal is recognized for its significant contributions to cardiovascular research, evidenced by its rank of #61 out of 387 in the Scopus database, placing it within the top 16% of journals in its field. Covering a broad range of topics within cardiology, the journal aims to disseminate high-quality research, clinical studies, and educational content, fostering knowledge sharing among researchers, clinicians, and students alike. While it does not currently offer open access, the journal maintains a commitment to advancing cardiovascular health through rigorous peer-reviewed articles. With a publication history that spans from 2013 to 2024, REVISTA ESPANOLA DE CARDIOLOGIA is an essential resource for those seeking to stay at the forefront of cardiology advancements and practices.

Current Heart Failure Reports

Uncovering Breakthroughs in Heart Failure Therapy
Publisher: SPRINGERNATUREISSN: 1546-9530Frequency: 6 issues/year

Current Heart Failure Reports, published by SpringerNature, is a leading journal dedicated to advancing the field of cardiology, specifically focusing on heart failure. With an impressive impact factor and a recognized reputation, this journal falls under the top quartiles in several categories, including Q1 in Cardiology and Cardiovascular Medicine and Emergency Medicine. Its range of topics encompasses both clinical and research insights into heart failure management, offering valuable perspectives aligned with the latest therapeutic advancements. Although it does not have open access options, researchers and practitioners can find profound studies and reviews aimed at improving patient care and outcomes in cardiovascular health. As the journal converges towards its 20th year in print, it continues to serve as a critical resource for academic professionals, providing a platform for high-quality research that shapes the future of heart failure treatments.

Cardiology Research and Practice

Innovative insights shaping the future of cardiology.
Publisher: HINDAWI LTDISSN: 2090-8016Frequency: 1 issue/year

Cardiology Research and Practice is a leading academic journal dedicated to advancing knowledge in the fields of cardiology and cardiovascular medicine. Published by HINDAWI LTD, this journal has been an inclusive platform for open access research since 2009, facilitating the dissemination of high-quality studies that contribute to the global scientific community. With an impact factor placing it in Q2 of its category in 2023, it underscores its importance in delivering innovative insights and discoveries that shape clinical practices and policies. The journal covers a broad scope of topics including, but not limited to, cardiovascular disease prevention, innovative treatment modalities, and emerging technologies, appealing to researchers, healthcare professionals, and students alike. Located in the United States with its international reach, Cardiology Research and Practice serves as a critical resource for those dedicated to improving patient outcomes and advancing the field of cardiology.

Journal of Cardiovascular Medicine

Connecting Research and Practice for Heart Health
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 1558-2027Frequency: 12 issues/year

Welcome to the Journal of Cardiovascular Medicine, a leading platform for the dissemination of high-quality research in the field of cardiology and cardiovascular medicine. Published by Lippincott Williams & Wilkins, this esteemed journal boasts an ISSN of 1558-2027 and an E-ISSN of 1558-2035, reflecting its commitment to accessible and innovative cardiovascular research. With a significant impact factor and ranked Q2 in both Cardiology and Cardiovascular Medicine as well as in Medicine (Miscellaneous) for 2023, the journal is recognized for its contributions to advancing knowledge and practice in this critical area of health. The journal disseminates original research, reviews, and clinical studies, aimed at clinicians, researchers, and healthcare professionals who are dedicated to improving cardiovascular health outcomes. With a continuous commitment to evolving research from 2006 to 2024, the journal is an essential resource for those looking to stay at the forefront of the latest discoveries and methodologies in cardiovascular medicine.

Cardiology Journal

Innovating the landscape of cardiovascular medicine.
Publisher: VIA MEDICAISSN: 1897-5593Frequency: 6 issues/year

Cardiology Journal, published by VIA MEDICA, stands as a prominent resource in the field of cardiology and cardiovascular medicine, with an ISSN of 1897-5593 and an E-ISSN of 1898-018X. Recognized for its Open Access model established since 1994, this journal facilitates widespread dissemination of critical research findings, allowing practitioners and researchers globally to access valuable insights without barriers. Based in Poland, with an address at UL SWIETOKRZYSKA 73, 80-180 GDANSK, it has achieved a respectable Q2 classification in 2023 for both Cardiology and Miscellaneous Medicine categories, reflecting its influence and quality within the scholarly community. With a Scopus ranking placing it at #117 out of 387 in Cardiology, it lies within the 69th percentile, underpinning its commitment to advancing knowledge in cardiovascular health. The journal’s converged years extending from 2006 to 2024 ensure it captures ongoing developments in a rapidly evolving field. As such, the Cardiology Journal serves as an indispensable platform for researchers, professionals, and students dedicated to exploring the frontiers of cardiac science and improving patient care.

Korean Circulation Journal

Pioneering Insights in Cardiology and Cardiovascular Medicine.
Publisher: KOREAN SOC CARDIOLOGYISSN: 1738-5520Frequency: 12 issues/year

Korean Circulation Journal, published by the Korean Society of Cardiology, has established itself as a prominent platform for disseminating research in the fields of Cardiology and Cardiovascular Medicine. With an ISSN of 1738-5520 and an E-ISSN of 1738-5555, this journal has been at the forefront of cardiovascular science since its inception in 2006 and is projected to continue until 2024. The journal's commitment to quality is reflected in its 2023 category quartiles, ranking in the second quartile (Q2) for both Cardiology and Internal Medicine, as well as its commendable Scopus rankings within the respective fields. Located in South Korea, the journal aims to bridge the gap between cutting-edge research and practical applications, serving as an invaluable resource for researchers, healthcare professionals, and students keen on advancing their understanding of cardiovascular health. Although currently not an open-access journal, it provides a wealth of knowledge that encourages evidence-based practice in clinical settings.

AMERICAN JOURNAL OF CARDIOLOGY

Elevating Standards in Cardiovascular Research and Practice
Publisher: EXCERPTA MEDICA INC-ELSEVIER SCIENCE INCISSN: 0002-9149Frequency: 24 issues/year

The American Journal of Cardiology is a leading peer-reviewed journal in the field of Cardiology and Cardiovascular Medicine, published by Excerpta Medica Inc-Elsevier Science Inc. Since its inception in 1958, the journal has consistently contributed to the advancement of cardiovascular research, providing a platform for groundbreaking studies and clinical findings that shape modern medical practices. With an impressive impact factor placing it in the Q1 category in its field for 2023, it ranks among the top journals in medicine, with a rank of #155 out of 387 in the Scopus database, reflecting its significance and rigorous editorial standards. The journal is committed to disseminating high-quality research that fosters innovation and enhances clinical outcomes in cardiology. Although it does not provide Open Access options, the American Journal of Cardiology remains an essential resource for researchers, healthcare professionals, and students looking to deepen their understanding of cardiovascular health.